Publication | Open Access

Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs

Drug TargetHealth SciencesCheckpoint Kinase 2Genotoxic DrugsMedicineRational Drug DesignNovel Pyrazole-benzimidazole ConjugatesPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyDrug DiscoveryDrug Resistance